| Title : What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors? - Mori_2006_Alzheimer.Dis.Assoc.Disord_20_S19 |
| Author(s) : Mori E , Hashimoto M , Krishnan KR , Doraiswamy PM |
| Ref : Alzheimer Disease & Associated Disorders , 20 :S19 , 2006 |
| Abstract : |
| PubMedSearch : Mori_2006_Alzheimer.Dis.Assoc.Disord_20_S19 |
| PubMedID: 16772752 |
| Title : Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study - Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755 |
| Author(s) : Heller JH , Spiridigliozzi GA , Crissman BG , Sullivan JA , Eells RL , Li JS , Doraiswamy PM , Krishnan KR , Kishnani PS |
| Ref : J Child Adolesc Psychopharmacol , 16 :755 , 2006 |
| Abstract : |
| PubMedSearch : Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755 |
| PubMedID: 17201619 |
| Title : Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease - Krishnan_2003_Am.J.Psychiatry_160_2003 |
| Author(s) : Krishnan KR , Charles HC , Doraiswamy PM , Mintzer J , Weisler R , Yu X , Perdomo C , Ieni JR , Rogers S |
| Ref : Am J Psychiatry , 160 :2003 , 2003 |
| Abstract : |
| PubMedSearch : Krishnan_2003_Am.J.Psychiatry_160_2003 |
| PubMedID: 14594748 |
| Title : Cholinergic therapy for Down's syndrome - |
| Author(s) : Kishnani PS , Sullivan JA , Walter BK , Spiridigliozzi GA , Doraiswamy PM , Krishnan KR |
| Ref : Lancet , 353 :1064 , 1999 |
| PubMedID: 10199357 |